Literature DB >> 33619029

Differential Outcome between BALB/c and C57BL/6 Mice after Escherichia coli O157:H7 Infection Is Associated with a Dissimilar Tolerance Mechanism.

Alan M Bernal1, Romina Jimena Fernández-Brando1, Andrea Cecilia Bruballa1, Gabriela A Fiorentino1,2, Gonzalo Ezequiel Pineda1, Elsa Zotta3, Mónica Vermeulen4, María Victoria Ramos1, Martin Rumbo5, Marina Sandra Palermo6.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) infections can result in a wide range of clinical presentations despite that EHEC strains belong to the O157:H7 serotype, one of the most pathogenic forms. Although pathogen virulence influences disease outcome, we emphasize the concept of host-pathogen interactions, which involve resistance or tolerance mechanisms in the host that determine total host fitness and bacterial virulence. Taking advantage of the genetic differences between mouse strains, we analyzed the clinical progression in C57BL/6 and BALB/c weaned mice infected with an E. coli O157:H7 strain. We carefully analyzed colonization with several bacterial doses, clinical parameters, intestinal histology, and the integrity of the intestinal barrier, as well as local and systemic levels of antibodies to pathogenic factors. We demonstrated that although both strains had comparable susceptibility to Shiga toxin (Stx) and the intestinal bacterial burden was similar, C57BL/6 showed increased intestinal damage, alteration of the integrity of the intestinal barrier, and impaired renal function that resulted in increased mortality. The increased survival rate in the BALB/c strain was associated with an early specific antibody response as part of a tolerance mechanism.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  EHEC; Shiga toxins; antibodies; defense mechanisms; intestinal infection; mouse model

Year:  2021        PMID: 33619029      PMCID: PMC8091094          DOI: 10.1128/IAI.00031-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Characterization of stx2 tubular response in a rat experimental model of hemolytic uremic syndrome.

Authors:  F Ochoa; N R Lago; E Gerhardt; C Ibarra; E Zotta
Journal:  Am J Nephrol       Date:  2010-08-20       Impact factor: 3.754

2.  Frontline Science: Abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes.

Authors:  Mariana Camila Gonçalves Miranda; Rafael Pires Oliveira; Lícia Torres; Sarah Leão Fiorini Aguiar; Natalia Pinheiro-Rosa; Luísa Lemos; Mauro Andrade Guimarães; Daniela Reis; Tatiany Silveira; Ênio Ferreira; Thaís Garcias Moreira; Denise Carmona Cara; Tatiani Uceli Maioli; Brian L Kelsall; Daniela Carlos; Ana Maria Caetano Faria
Journal:  J Leukoc Biol       Date:  2019-07-16       Impact factor: 4.962

3.  Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis.

Authors:  Silvia Melgar; Marketa Drmotova; Erika Rehnström; Liselotte Jansson; Erik Michaëlsson
Journal:  Cytokine       Date:  2006-11-07       Impact factor: 3.861

4.  Retinoic acid-induced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation.

Authors:  Astrid Menning; Christoph Loddenkemper; Astrid M Westendorf; Balint Szilagyi; Jan Buer; Christiane Siewert; Alf Hamann; Jochen Huehn
Journal:  Eur J Immunol       Date:  2010-09       Impact factor: 5.532

5.  Age-specific frequencies of antibodies to Escherichia coli verocytotoxins (Shiga toxins) 1 and 2 among urban and rural populations in southern Ontario.

Authors:  Mohamed A Karmali; Mariola Mascarenhas; Martin Petric; Lucie Dutil; Kris Rahn; Kerstin Ludwig; Gerald S Arbus; Pascal Michel; Philip M Sherman; Jeff Wilson; Roger Johnson; James B Kaper
Journal:  J Infect Dis       Date:  2003-11-14       Impact factor: 5.226

6.  Cooperative Metabolic Adaptations in the Host Can Favor Asymptomatic Infection and Select for Attenuated Virulence in an Enteric Pathogen.

Authors:  Karina K Sanchez; Grischa Y Chen; Alexandria M Palaferri Schieber; Samuel E Redford; Maxim N Shokhirev; Mathias Leblanc; Yujung M Lee; Janelle S Ayres
Journal:  Cell       Date:  2018-08-09       Impact factor: 41.582

7.  Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods.

Authors:  Romina J Fernández-Brando; Leticia V Bentancor; María Pilar Mejías; María Victoria Ramos; Andrea Exeni; Claudia Exeni; María del Carmen Laso; Ramón Exeni; Martín A Isturiz; Marina S Palermo
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  Innate secretory antibodies protect against natural Salmonella typhimurium infection.

Authors:  Odilia L C Wijburg; Tania K Uren; Kim Simpfendorfer; Finn-Eirik Johansen; Per Brandtzaeg; Richard A Strugnell
Journal:  J Exp Med       Date:  2006-01-03       Impact factor: 14.307

9.  Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease.

Authors:  Sophie Dennhardt; Wiebke Pirschel; Bianka Wissuwa; Christoph Daniel; Florian Gunzer; Sandro Lindig; Anna Medyukhina; Michael Kiehntopf; Wolfram W Rudolph; Peter F Zipfel; Matthias Gunzer; Marc Thilo Figge; Kerstin Amann; Sina M Coldewey
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

10.  Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.

Authors:  Elisa Ylinen; Saara Salmenlinna; Jani Halkilahti; Timo Jahnukainen; Linda Korhonen; Tiia Virkkala; Ruska Rimhanen-Finne; Matti Nuutinen; Janne Kataja; Pekka Arikoski; Laura Linkosalo; Xiangning Bai; Andreas Matussek; Hannu Jalanko; Harri Saxén
Journal:  Pediatr Nephrol       Date:  2020-04-22       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.